Document is current
Any future updates will be listed below
-
Authors
Kaivola, Karri http://orcid.org/0000-0003-1218-4014
Salmi, Samuli J.
Jansson, Lilja
Launes, Jyrki http://orcid.org/0000-0002-3477-398X
Hokkanen, Laura http://orcid.org/0000-0001-8342-9248
Niemi, Anna-Kaisa
Majamaa, Kari
Lahti, Jari http://orcid.org/0000-0002-4310-5297
Eriksson, Johan G.
Strandberg, Timo
Laaksovirta, Hannu
Tienari, Pentti J.
-
Funding
Funding for this research was provided by:
Suomen Kulttuurirahasto
Paulon Säätiö
Suomen Aivosäätiö
Sigrid Juséliuksen Säätiö
Helsingin ja Uudenmaan Sairaanhoitopiiri
ALS tuttu ry.
Academy of Finland
- License Information
-
More Information
Article History
Received: 12 July 2020
Accepted: 14 October 2020
First Online: 9 November 2020
Ethics approval and consent to participate
: The study was approved by the Ethics Committee of the Helsinki University Central Hospital (diary number 401/13/03/01/09 and HUS/1720/2019). All individuals or their next-of-kin gave a written informed consent.
: Not applicable.
: Pentti J. Tienari holds a patent on <i>C9orf72</i> in diagnostics and treatment of ALS/FTD. Other authors declare that they have no competing interests.
